Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Comparison of Fluorescence and Bioluminescence Imaging Using iRFP & Luciferase Labeled 4T1 Breast Cancer Model

Not Accessible

Your library or personal account may give you access

Abstract

Accuracy of the bioluminescence imaging drastically depends on the delivery and perfusion of the i.p. injected luciferin and its time-varying signals. The advent of the iRFPs will lead to widespread use of fluorescence imaging instead.

© 2022 The Author(s)

PDF Article
More Like This
Multi-modality X-ray/Optical Tomographic Imaging Guided Radiotherapy Research Platform: In Vivo Optical Background Subtraction for Sensitive Tumor Detection

Junwei Shi, Yidong Yang, Thirupandiyur S. Udayakumar, Anis Ahmad, Brian Marples, Nesrin Dogan, John Chetley Ford, and Alan Pollack
SW1D.7 Optical Tomography and Spectroscopy (OT&S) 2020

Optical Metabolic Imaging of TWIST Inhibition in 4T1 Breast Cancer Cells

Mason Harper, Kinan Alhallak, Lisa Rebello, Khue Nguyen, Sruthi Ravindranathan, David Lee, Nicholas Greene, Tim Muldoon, David Zaharoff, Kyle Quinn, and Narasimhan Rajaram
OmS2D.3 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2017

Ultra-sensitive single pixel bioluminescence tomography for in vivo cell tracking

Zhishen Tong, Zijian Deng, and Ken Kang-Hsin Wang
JTu3A.45 Clinical and Translational Biophotonics (Translational) 2022

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.